Oncosynergy
Get Full AccessDescription
- Outsmarting therapy resistance in cancer. Bay Area seed-stage biotechnology company developing novel therapies for highly aggressive and therapy resistant cancers through a targeted synergy approach. Our lead drug OS2966 blocks the critical path for therapy resistance in cancer and holds promise for significantly improving patient outcomes.
-
Headquarters:380 Greenwich Avenue , Greenwich, Connecticut, United States
More -
Phone Number:
-
-
Employees:7
-
Revenue:$1 - 10M
-
Legal Name:Oncosynergy
-
Oncosynergy's Social Media
-
Is this data correct?
-
| NAICS Code: 541713 |
Show More
Sell more in less time!
Buyer intent data, anonymous visitor identification, first party data integration backed by a massive contact database that will supercharge your sales team. Schedule a demo to learn more!
Frequently Asked Questions regarding Oncosynergy
-
Where are Oncosynergy's Headquarters?
Oncosynergy's Headquarters are in 380 Greenwich Avenue ,Greenwich,Connecticut,United States
-
What is Oncosynergy's Revenue?
Oncosynergy's revenue is $1 - 10M
-
What is Oncosynergy's NAICS code?
Oncosynergy's NAICS code is 541713
-
How many employees are working in Oncosynergy
Oncosynergy has 7 employees
-
What is Oncosynergy's Industry?
Oncosynergy is in the industry of Biotechnology
-
Who is Oncosynergy's CEO?
Oncosynergy's CEO is Anne-Marie Carbonell
-
Who is Oncosynergy's Vice President Of Corporate Operations?
Oncosynergy's Vice President Of Corporate Operations is Ambar